JPH062048B2 - キヤンビローバクター ジエジユニ培養基の添加剤 - Google Patents
キヤンビローバクター ジエジユニ培養基の添加剤Info
- Publication number
- JPH062048B2 JPH062048B2 JP58165842A JP16584283A JPH062048B2 JP H062048 B2 JPH062048 B2 JP H062048B2 JP 58165842 A JP58165842 A JP 58165842A JP 16584283 A JP16584283 A JP 16584283A JP H062048 B2 JPH062048 B2 JP H062048B2
- Authority
- JP
- Japan
- Prior art keywords
- cefoperazone
- rifampicin
- mixture
- additive
- amphotericin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000654 additive Substances 0.000 title claims description 36
- 239000000203 mixture Substances 0.000 claims description 40
- 239000002609 medium Substances 0.000 claims description 36
- 230000000996 additive effect Effects 0.000 claims description 27
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 claims description 24
- 229960004682 cefoperazone Drugs 0.000 claims description 24
- 230000000845 anti-microbial effect Effects 0.000 claims description 16
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims description 14
- 229960001225 rifampicin Drugs 0.000 claims description 14
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 claims description 12
- 108010078777 Colistin Proteins 0.000 claims description 11
- 229960003346 colistin Drugs 0.000 claims description 11
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 claims description 11
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 claims description 11
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 claims description 11
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 claims description 9
- 239000013543 active substance Substances 0.000 claims description 9
- 229960003942 amphotericin b Drugs 0.000 claims description 9
- 230000000721 bacterilogical effect Effects 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229930183010 Amphotericin Natural products 0.000 claims description 3
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000589876 Campylobacter Species 0.000 claims description 3
- 229940009444 amphotericin Drugs 0.000 claims description 3
- 241000589875 Campylobacter jejuni Species 0.000 claims 4
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 description 11
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 5
- 244000052616 bacterial pathogen Species 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241001494479 Pecora Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- -1 trimethopurine Chemical compound 0.000 description 3
- 108010001478 Bacitracin Proteins 0.000 description 2
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 2
- 229960003071 bacitracin Drugs 0.000 description 2
- 229930184125 bacitracin Natural products 0.000 description 2
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 2
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 2
- 229960001139 cefazolin Drugs 0.000 description 2
- 239000007382 columbia agar Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229960002950 novobiocin Drugs 0.000 description 2
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823238819 DE3238819A1 (de) | 1982-10-20 | 1982-10-20 | Zusatz fuer naehrboeden zur zuechtung von campylobacter jejuni |
| DE3238819.5 | 1982-10-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6037978A JPS6037978A (ja) | 1985-02-27 |
| JPH062048B2 true JPH062048B2 (ja) | 1994-01-12 |
Family
ID=6176152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58165842A Expired - Lifetime JPH062048B2 (ja) | 1982-10-20 | 1983-09-07 | キヤンビローバクター ジエジユニ培養基の添加剤 |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPH062048B2 (enExample) |
| BE (1) | BE897927A (enExample) |
| DE (1) | DE3238819A1 (enExample) |
| FR (1) | FR2534929B1 (enExample) |
| GB (1) | GB2129013B (enExample) |
| IT (1) | IT1164439B (enExample) |
| NL (1) | NL8303506A (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2301211C3 (de) * | 1973-01-11 | 1978-06-22 | C.H. Boehringer Sohn, 6507 Ingelheim | Synthetisches Nährmedium für Mikroorganismen |
| US4229530A (en) * | 1978-08-29 | 1980-10-21 | Board Of Regents, University Of Texas System | Methods and media for rapid detection of pathogenic neisseria |
-
1982
- 1982-10-20 DE DE19823238819 patent/DE3238819A1/de active Granted
-
1983
- 1983-09-07 JP JP58165842A patent/JPH062048B2/ja not_active Expired - Lifetime
- 1983-09-20 IT IT22931/83A patent/IT1164439B/it active
- 1983-09-26 GB GB08325721A patent/GB2129013B/en not_active Expired
- 1983-10-05 BE BE6/47883A patent/BE897927A/fr not_active IP Right Cessation
- 1983-10-12 NL NL8303506A patent/NL8303506A/nl not_active Application Discontinuation
- 1983-10-19 FR FR8316656A patent/FR2534929B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1164439B (it) | 1987-04-08 |
| FR2534929B1 (fr) | 1985-11-22 |
| IT8322931A0 (it) | 1983-09-20 |
| BE897927A (fr) | 1984-01-30 |
| GB2129013B (en) | 1985-09-25 |
| FR2534929A1 (fr) | 1984-04-27 |
| DE3238819C2 (enExample) | 1990-04-12 |
| IT8322931A1 (it) | 1985-03-20 |
| DE3238819A1 (de) | 1984-04-26 |
| GB8325721D0 (en) | 1983-10-26 |
| JPS6037978A (ja) | 1985-02-27 |
| GB2129013A (en) | 1984-05-10 |
| NL8303506A (nl) | 1984-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Costa et al. | Evaluation antibacterial and antibiofilm activity of the antimicrobial peptide P34 against Staphylococcus aureus and Enterococcus faecalis | |
| Sharma et al. | Functional characterization of biomedical potential of biosurfactant produced by Lactobacillus helveticus | |
| Kamaguchi et al. | Effect of Porphyromonas gingivalis vesicles on coaggregation of Staphylococcus aureus to oral microorganisms | |
| US6207411B1 (en) | Bacteriocins | |
| FI103861B (fi) | Uudet bakteriosiinikoostumukset käytettäväksi parempina laaja-alaisina bakterisideina | |
| US7026353B2 (en) | Inhibition of Gram positive bacteria | |
| Twomey et al. | Recipe for success: Suggestions and recommendations for the isolation and characterisation of bacteriocins | |
| Sparo et al. | Partial characterization of enterocin MR99 from a corn silage isolate of Enterococcus faecalis | |
| Majhenič et al. | DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221 | |
| Osmanagaoglu et al. | A probiotic bacterium, Pediococcus pentosaceus OZF, isolated from human breast milk produces pediocin AcH/PA-1 | |
| KR20020091498A (ko) | 항균 펩타이드 물질을 생산하는 유산균 락토코커스 락티스bh5(케이씨씨엠 10275) | |
| Weissfeld et al. | Rapid isolation of Yersinia spp. from feces | |
| Voth et al. | Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains of Clostridium sordellii | |
| EP0573768B1 (en) | Multiple bacteriocin producing lactococcus and compositions | |
| Gholami et al. | Comparison of antibiotics and bacteriocins antibacterial activity on Xanthomonas citri subsp. citri | |
| Ahmad et al. | Pseudomonas putida strain FStm2 isolated from shark skin: a potential source of bacteriocin | |
| AU2017296061B2 (en) | Lantibiotic variants and uses thereof | |
| KR100351622B1 (ko) | 신규 락토바실러스 속 (lactobacillus sp.)mt-1077 및 그로부터 생산되는 신규 박테리오신 | |
| JPH062048B2 (ja) | キヤンビローバクター ジエジユニ培養基の添加剤 | |
| JP2001523970A (ja) | 感受性試験および抗菌治療のアジュバントとしてのベタイン | |
| Conte et al. | Listeria monocytogenes infection of Caco-2 cells: role of growth temperature | |
| Angius et al. | Nutritionally variant streptococci interfere with streptococcus mutans adhesion properties and biofilm formation | |
| Prema et al. | Detection, purification and efficacy of warnerin produced by Staphylococcus warneri | |
| US6037140A (en) | Selective media for the culture and isolation of gram bacteria, antibiotic composition | |
| US20030104513A1 (en) | Betaines as adjuvants to susceptibility testing and antimicrobial therapy |